Skip to content

Prehabilitation of Elderly Patients With Frailty Syndrome Before Elective Surgery (PRAEP-GO)

Prehabilitation of Elderly Frail or Pre-frail Patients Prior to Elective Surgery - a Randomized Controlled Multicenter Study (PRAEP-Go)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04418271
Enrollment
1199
Registered
2020-06-05
Start date
2020-06-30
Completion date
2024-12-19
Last updated
2025-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frail Elderly, Frailty

Keywords

Prehabilitation, Physiotherapy, Exercise Therapy, Rehabilitation, Nutritional Intervention, Multidisciplinary Intervention, Frailty, Surgery

Brief summary

The aim of the study is to evaluate the effect of a shared decision-making conference and three-week prehabilitation program on the outcome care dependency one year after surgery. The cost-effectiveness of the intervention will also be evaluated in this N = 1400 patient, national multicenter, assessor-blinded, randomized, pragmatic, controlled, parallel-group, clinical trial. The objective of PRÄP-GO is to establish and employ a suitable preoperative case-care management system to improve the short and long-term outcome of elderly surgical patients with signs of a frailty syndrome, improving postoperative quality of life and reducing care dependency by a three-week individualized prehabilitation program.

Interventions

The participants in the intervention group take part in a shared decision-making (SDM) conference to plan the intervention. The therapeutic content of the prehabilitation is defined individually for each patient in the SDM conference. Prehabilitation will be a structured and individually tailored 3-week program.

Sponsors

Ludwig-Maximilians - University of Munich, The Institute for Medical Information Processing, Biometry, and Epidemiology
CollaboratorUNKNOWN
Technische Universität Berlin
CollaboratorOTHER
BARMER
CollaboratorOTHER
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Patients with frailty syndrome (≥1 of the standardized parameters (Pre-Frail = 1-2; Frail≥3) according to Fried et al.(2001) are offered randomised participation in the new form of care.

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Study patients: Inclusion Criteria: * Age ≥ 70 years * Consent by Patient or Legal Representative * Elective surgery planned * Expected anesthesia duration≥ 60 min * Statutory health insurance * Frailty syndrome (≥1 positive out of 5 standardized parameters according to the Physical Frailty Phenotype according to Fried et. al.)

Exclusion criteria

* Severe cardiac or pulmonary disease (NYHA IV, Gold IV) * Intracranial interventions * Moribund patients (palliative situation) * Not enough language skills * Participation in another interventional rehabilitation study or other interventional clinical trial that has not been approved by the study management committee (Exception: Participation in adjuvant intervention study)

Design outcomes

Primary

MeasureTime frameDescription
Degree of care dependencyUp to one yearAssessment results in a degree of care dependency from personal help according to the German dependency assessment (= Neues Begutachtungs-Assessment (NBA)) (Wingenfeld et al., 2008). The results of the assessments ranges between 0 and 100 points, which are transformed into a 0-5 ordinal scale. Higher points in the assessments indicate higher demand of care dependency. Accordingly, higher numbers on the ordinal scale indicate a higher level of care dependency as defined in the German statutory care insurance program.

Secondary

MeasureTime frameDescription
Timed Up & Go Test (TUGUp to one yearTimed Up & Go Test (TUG) to test mobility and body balance
Disability by WHODAS 2.0Up to one yearPatient- or proxy-reported functioning and disability is measured by the WHO Disability Assessment Schedule (WHODAS 2.0, 12-item version.
Arm circumferenceUp to one yearArm circumference is measured in a standardized position and documented in centimeter.
Calf circumferenceUp to one yearCalf circumference is measured in a standardized position and documented in centimeter.
Nutritional StatusUp to one yearChanges of nutritional status after elective surgery.
Change in body weightUp to one yearChanges in body weight measured in kg.
Instrumental Activities of daily living (IADL)Up to one yearInstrumental Activities of daily living (IADL) using the questionnaire by Lawton and Brody.
Functional enduranceUp to one yearFunctional endurance is measured using the 2-Minute-Step-Test (2-MST). The patient steps in place, raising each leg to a marker. The markers height is derived from biometrical measures of the patient. The assessor counts each step of the right leg in which the knee of the patient passes the marker. Higher counts of steps indicates better functional endurance.
Function of the respiratory systemUp to one yearThe function of the respiratory system is assessed by expiratory peak flow measurement as surrogate parameter.
DepressionUp to one yearDepression is measured by frequency of depressive symptoms; Patient Health Questionnaire-8 (PHQ-8)\]
AnxietyUp to one yearAnxiety is measured frequency of anxiety symptoms; Generalized Anxiety Disorder Scale-7 (GAD-7)
Health related quality of lifeUp to one yearHealth related quality of life is measured with EQ-5D-5L questionnaire.
Stair climbing speedUp to one yearStair climbing speed test
FallsUp to one yearIncidence of falls
Fear of FallingUp to one yearActivities-Specific Balance Confidence (ABC)-6-Scale. The scale consists of 6 questions who are rated on a 0-100 NRS-scale. The total result of the ABC-6-scale comprises of the average of all 6 items.
Satisfaction with the intervention: ZUF-8Up to one yearThe satisfaction of the patient is measured with the questionnaire on patient satisfaction (ZUF-8). The ZUF-8 is a questionnaire on patient satisfaction after treatment. It consists of 8 questions which results in a score between 0 and 24 points, with higher values.indicating higher levels of satisfaction.
Admission Intensive Care Unit (ICU) Admission rate on Intensive Care Unit (ICU)Participants are followed up for the duration of rehabilitation, an expected average of 1 day]Admission rate (planned / unplanned) on ICU
Duration of hospital stayParticipants are followed up for the duration of rehabilitation, an expected average of 7 days]Time in hospital
Postoperative functional mobilityUp to one yearPostoperative complication of mobilization speed measured with CHARMI
Length of stay Intensive Care UnitParticipants are followed up for the duration of rehabilitation, an expected average of 1 day]Intensive care unit length of stay describes every day spent in an ICU bed.
MortalityUp to one yearData from patient records and residents' registration
Barthel IndexUp to one yearLevel of care dependency after surgery reported as Barthel Index
Change in NBA scoreUp to one yearAssessment results according to the German dependency assessment (= Neues Begutachtungs-Assessment (NBA)) (Wingenfeld et al., 2008) using the results of the assessments on the scale from 0 to 100 points
NBA domain changeUp to one yearChange in individual domains of the German dependency assessment (= Neues Begutachtungs-Assessment (NBA)).
Surrogate for Neurocognitive Disorder (NCD)Up to one yearFrequency of neurocognitive vulnerability at 3 or 12 months as surrogate for NCD is measured as composite score: 1. Frequency of cognitive impairment/vulnerability is calculated from a change in composite of MiniCog, ANT, TMT-B and MOCA 2. subjective concern (MMQ) and 3. IADL/ADL
Screening tool for cognitive vulnerabilityUp to one yearCognitive vulnerability is suspected by limited MiniCog-test result. The MiniCog consists of two items, the word recall test and the clock-drawing test. Performance in these test is rated on a scale ranging from 0 - 5, with \<3 points indicating a cognitive vulnerability.
Muscle strengthUp to one yearMuscle strength measured by handgrip strength
Functional mobilityUp to one yearFunctional mobility is measured with gait speed over 15ft
Dementia risk assessed by MOCAUp to one yearDementia risk is assessed by Montreal Cognitive Assessment (MOCA-30) deterioration (change) and its absolute value if \< 26.
DeliriumUp to one yearDelirium as perioperative complication assessed until hospital discharge using billing data.
FrailtyUp to one yearFrailty is operationalized using modified Fried frailty criteria. Frailty scores from 0 to 5 (i.e., 1 point for each component; 0 = best to 5 = worst) represent robust (0), pre-frail (1-2), and frail (3-5) health status.
Perioperative complications by Clavien-DindoUp to hospital dischargePerioperative complications assessed using Clavien Dindo till hospital discharge
Every mobilityUp to one yearLevel of everyday mobility using Life-Space Assessment (LSA)
Autonomy PreferenceAt the beginning of the observationExtent of patients' autonomy preference concerning medical decisions; Autonomy-Preference-Index, modified German version (API-Dm). The scale consists of a 11-item questionnaire with 4 questions on preferred autonomy in health-related decisions and 7 items on information preference. The total results of the API and both subscales are transformed into a 0 - 100 scale with higher values indicating higher levels on autonomy and information preference, respectively.
Extent of involvement in shared decision-making processAt the beginning of the observationExtent of patients, relatives and health professionals' involvement in shared decision-making process; 9-Item Shared Decision Making Questionnaire (SDM-Q-9/SDM-Q-Doc)

Other

MeasureTime frameDescription
Necessity for follow-up treatment and rehabilitationUp to one yearAssessment if a follow-up treatment or rehabilitation is necessary after the hospital stay.
Count of new discharge diagnosesParticipants are followed up for the duration of rehabilitation, an expected average of 7 days]New medical diagnoses at hospital discharge compared to baseline are assessed.
Count of new discharge medicationParticipants are followed up for the duration of rehabilitation, an expected average of 7 days]New medication at hospital discharge compared to baseline is assessed.
Duration of rehabilitationParticipants are followed up for the duration of rehabilitation, an expected average of 25 days]Patient record data, discharge letter
Health economic benefitUp to one yearScreeningThe health economic benefit of the intervention (prehabilitation) will be compared to standard of care in the German health care system using a health cost analysis framework.
Exercise adherence and planned prehabilitation compositionUp to one yearAssessment of the appropriateness of the quantity and quality of the exercise interventions compared to exercise prescription guidelines.
Patient supportUp to one yearPatient support by need/prescription of assistive devices (Hilfsmittel) and therapeutic treatment (Heilmittel).
PolypharmacyUp to one yearMeasured by number of drug agents
Alcohol UseUp to one yearMeasured by Alcohol Use Disorders Identification Test (AUDIT-C)
Tobacco UseUp to one yearMeasured by Fagerstrom (Fagerstrom & Schneider, 1989)
SarcopeniaUp to one yearSarcopenia is evaluated as a composite measure by three criteria that are assessed: 1) low muscle strength (hand grip strength), 2) low muscle quantity (calf circumference) and 3) low physical performance (gait speed or TUG).
Social situation measurement 1Up to one yearThe social situation 1 of the patient is measured by a Questionnaire for Social Situation (SOS, Subscales 1 and 2).
Social situation measurement 2Up to one yearThe social situation 2 of the patient is measured by BSSS, 8-items
Pain: Numeric rating scaleUp to one yearPain is measured with a pain score Numeric rating scale (0-10), a higher score indicates more pain.
LonelinessUp to one yearFrequency of sensations of loneliness; 3-item UCLA Loneliness Scale
Adverse Discharge DispositionParticipants are followed up after hospital discharge for 1 dayAdverse discharge disposition other than to home and planned rehabilitation facility.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 17, 2026